MOTS-c vs Tesamorelin
Well Studied vs FDA Approved
synergistic Mechanism-based · 51% MOTS-c helps counteract the insulin-disrupting effects of Tesamorelin. A smart combination — the insulin sensitizer mitigates metabolic side effects.
Molecular Data
MOTS-c Tesamorelin
Weight 2,174.6 Da 5,135.9 Da
Half-life ~30 minutes 26-38 minutes
Chain 16 amino acids 44 amino acids
Type Mitochondrial-derived peptide (MDP) GHRH analog
Key Benefits
MOTS-c
01 Enhanced insulin sensitivity (~30% improvement)
02 Improved glucose metabolism and tolerance
03 AMPK pathway activation
04 Mitochondrial function optimization
05 Exercise performance enhancement (12-15% improvement)
06 Potential lifespan extension (6.4% median increase in mice)
Tesamorelin
01 FDA-approved formulation
02 Selective visceral fat targeting (15-20% reduction)
03 Proven clinical efficacy
04 Standardized dosing
05 37% liver fat reduction in NAFLD
06 Preserved subcutaneous fat
Dosing Protocols
MOTS-c
Start 5mg daily, increase to 10-15mg based on goals / Daily for metabolic support, or 3x weekly for anti-aging
Metabolic health 5-10mg Once daily
Anti-aging protocol 15mg 3x weekly
Exercise performance 10-15mg Pre-workout
Conservative start 5mg Once daily
Tesamorelin
1.4-2mg daily (FDA-approved: 2mg for HIV lipodystrophy) / Once daily (evening preferred for GH rhythm)
HIV Lipodystrophy (FDA-approved) 1.4mg Once daily
Visceral Fat Reduction 2mg Once daily
Anti-aging/Body Composition 1-2mg 5-7x weekly
NAFLD Treatment 2mg Once daily (12 months)
Cognitive Enhancement 1mg Once daily (20 weeks)
Side Effects
MOTS-c
Generally well-tolerated in animal studies with minimal side effects
Mild injection site reactions (redness, swelling)
Tesamorelin
Injection site reactions (17%)
Joint pain (13%)
Water retention
Contraindications
Pregnancy or breastfeeding
WADA prohibited substance (banned for athletic competition)
Limited long-term human safety data
Active malignancy
Pituitary disorders
Pregnancy
Research Evidence
MOTS-c Tesamorelin
Status Well Studied FDA Approved
References 5 studies 5 studies
Latest August 2025 June 2025
FDA Approved No Yes
More comparisons: Metformin
This comparison is for educational and research purposes only. Consult a healthcare professional before use.